{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:57:21Z","timestamp":1757620641630,"version":"3.44.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00203-025-04407-y","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T08:05:36Z","timestamp":1753949136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From pathogenicity to therapy: Investigating the Therapeutic Potential of Bacillus anthracis Anthrax Toxin in Novel Cancer Therapies and Oncological Research"],"prefix":"10.1007","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-5296","authenticated-orcid":false,"given":"Farhad","family":"Moradi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Ghorbanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9022-948X","authenticated-orcid":false,"given":"Nahal","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khashyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahrokh Rajaee","family":"Behbahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Nasrollahian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Nasoohian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar Nayerain","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"32","key":"4407_CR1","doi-asserted-by":"publisher","first-page":"e2210179119","DOI":"10.1073\/pnas.2210179119","volume":"119","author":"K Aktories","year":"2022","unstructured":"Aktories K (2022) Treatment of ovarian cancer with modified anthrax toxin. Proc Nat Acad Sci 119(32):e2210179119. https:\/\/doi.org\/10.1073\/pnas.2210179119","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"4407_CR2","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3892\/ijo.2016.3431","volume":"48","author":"S Al-Dimassi","year":"2016","unstructured":"Al-Dimassi S, Salloum G, Saykali B, Khoury O, Liu S, Leppla SH, Abi-Habib R, El-Sibai M (2016) Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion. Int J Oncol 48(5):1913\u20131920. https:\/\/doi.org\/10.3892\/ijo.2016.3431","journal-title":"Int J Oncol"},{"issue":"22","key":"4407_CR3","doi-asserted-by":"publisher","first-page":"15730","DOI":"10.1074\/jbc.M113.538587","volume":"30","author":"MT Ar\u00e9valo","year":"2014","unstructured":"Ar\u00e9valo MT, Navarro A, Arico CD, Li J, Alkhatib O, Chen S, Diaz-Ar\u00e9valo D, Zeng M (2014) Targeted silencing of anthrax toxin receptors protects against anthrax toxins. J Biol Chem 30(22):15730\u201315738. https:\/\/doi.org\/10.1074\/jbc.M113.538587","journal-title":"J Biol Chem"},{"key":"4407_CR4","doi-asserted-by":"publisher","first-page":"101501","DOI":"10.1016\/j.nmni.2024.101501","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Biswas A, Mohanto S, Srivastava S, Hussain MS, Ahmed M, Subramaniyan V (2024) Anthrax: a narrative review. New Microbes New Infections 10:62:101501. https:\/\/doi.org\/10.1016\/j.nmni.2024.101501","journal-title":"New Microbes New Infections"},{"issue":"5","key":"4407_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1134\/s1068162008050063","volume":"1","author":"EV Belova","year":"2008","unstructured":"Belova EV, Kolesnikov AV, MIu Z, Dubile\u012d SA, Diatlov IA, Shemiakin IG (2008) Characteristics of the immune response to the lethal toxin of Bacillus anthracis. Bioorg Khim 1(5):639\u2013644. https:\/\/doi.org\/10.1134\/s1068162008050063","journal-title":"Bioorg Khim"},{"issue":"1","key":"4407_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4161\/cc.1.1.95","volume":"1","author":"JF Bodart","year":"2002","unstructured":"Bodart JF, Chopra A, Liang X, Duesbery N (2002) Anthrax, MEK and cancer. Cell Cycle 1(1):7\u201312. https:\/\/doi.org\/10.4161\/cc.1.1.95","journal-title":"Cell Cycle"},{"key":"4407_CR7","doi-asserted-by":"publisher","unstructured":"Canine and Human Osteosarcoma Cells (2020) Toxins (Basel) 12(10):614. https:\/\/doi.org\/10.3390\/toxins12100614","DOI":"10.3390\/toxins12100614"},{"key":"4407_CR8","unstructured":"Centers for Disease Control and Prevention (CDC) (2024) Cancer risk factors, November 19. https:\/\/www.cdc.gov\/cancer\/risk-factors\/index.html"},{"key":"4407_CR9","unstructured":"Centers for Disease Control and Prevention (cdc) (2025) Bioterrorism and anthrax: the threat. April 13, 2025. https:\/\/www.cdc.gov\/anthrax\/bioterrorism\/index.html"},{"issue":"5","key":"4407_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.14712\/fb2015061050178","volume":"1","author":"P Cie\u015blik","year":"2015","unstructured":"Cie\u015blik P, Knap J, Ko\u0142odziej M, Mirski T, Joniec J, Graniak G et al (2015) Real-time PCR identification of unique Bacillus anthracis sequences. Folia Biol (Praha) 1(5):178\u2013183. https:\/\/doi.org\/10.14712\/fb2015061050178","journal-title":"Folia Biol (Praha)"},{"issue":"2\u20133","key":"4407_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.20471\/LO.2019.47.02-03.17","volume":"47","author":"F Cmre\u010dak","year":"2019","unstructured":"Cmre\u010dak F, Andra\u0161ek I, Solak-Meki\u0107 M, Ravli\u0107 M, Beketi\u0107-Ore\u0161kovi\u0107 L (2019) Modern radiotherapy techniques. Libri Oncologici Croatian J Oncol 47(2\u20133):91\u201397. https:\/\/doi.org\/10.20471\/LO.2019.47.02-03.17","journal-title":"Libri Oncologici: Croatian J Oncol"},{"key":"4407_CR12","doi-asserted-by":"publisher","unstructured":"Darwich ME (2015) Potency and selectivity of a urokinase activated recombinant anthrax toxin to acute myeloid leukemia (AML) cells. (C2015). Doctoral dissertation, Lebanese American University. https:\/\/doi.org\/10.26756\/th.2015.53","DOI":"10.26756\/th.2015.53"},{"issue":"5","key":"4407_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jmb.2017.01.015","volume":"10","author":"D Das","year":"2017","unstructured":"Das D, Krantz BA (2017) Secondary structure preferences of the anthrax toxin protective antigen translocase. J Mol Biol 10(5):753\u2013762. https:\/\/doi.org\/10.1016\/j.jmb.2017.01.015","journal-title":"J Mol Biol"},{"key":"4407_CR14","doi-asserted-by":"publisher","unstructured":"Duru N, Pawar NR, Martin EW, Buzza MS, Conway GD, Lapidus RG, Liu S, Reader J, Rao GG, Roque DM, Leppla SH (2022) Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases. Proceedings of the national academy of sciences 119(28):e2201423119. https:\/\/doi.org\/10.1073\/pnas.2201423119","DOI":"10.1073\/pnas.2201423119"},{"issue":"2","key":"4407_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/ol.2020.12424","volume":"21","author":"D El-Chami","year":"2021","unstructured":"El-Chami D, Al Haddad M, Abi-Habib R, El-Sibai M (2021) Recombinant anthrax lethal toxin inhibits cell motility and invasion in breast cancer cells through the dysregulation of Rho GTPases. Oncol Lett 21(2):163. https:\/\/doi.org\/10.3892\/ol.2020.12424","journal-title":"Oncol Lett"},{"issue":"6","key":"4407_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/pro.3613","volume":"28","author":"ES Fischer","year":"2019","unstructured":"Fischer ES, Campbell IVWA, Liu S, Ghirlando R, Fattah RJ, Bugge TH, Leppla SH (2019) Bismaleimide cross-linked anthrax toxin forms functional octamers with high specificity in tumor targeting. Protein Sci 28(6):1059\u20131070. https:\/\/doi.org\/10.1002\/pro.3613","journal-title":"Protein Sci"},{"issue":"4","key":"4407_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2174\/1389203023380567","volume":"1","author":"AE Frankel","year":"2002","unstructured":"Frankel AE, Powell BL, Duesbery NS, Vande Woude GF, Leppla SH (2002) Anthrax fusion protein therapy of cancer. Curr Protein Pept Sci 1(4):399\u2013407. https:\/\/doi.org\/10.2174\/1389203023380567","journal-title":"Curr Protein Pept Sci"},{"issue":"9","key":"4407_CR18","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3390\/biomedicines12092158","volume":"23","author":"R Ghemrawi","year":"2024","unstructured":"Ghemrawi R, Abuamer L, Kremesh S, Hussien G, Ahmed R, Mousa W, Khoder G, Khair M (2024) Revolutionizing cancer treatment: recent advances in immunotherapy. Biomedicines 23(9):2158. https:\/\/doi.org\/10.3390\/biomedicines12092158","journal-title":"Biomedicines"},{"issue":"3","key":"4407_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/15569543.2014.897731","volume":"1","author":"WA Hall","year":"2000","unstructured":"Hall WA, Li YM, Vallera DA (2000) Diphtheria toxin-based targeted toxins that target glioblastoma multiform. Toxin Rev 1(3):119\u2013124. https:\/\/doi.org\/10.3109\/15569543.2014.897731","journal-title":"Toxin Reviews"},{"issue":"4","key":"4407_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1051\/bmdcn\/2017070423","volume":"24","author":"CY Huang","year":"2017","unstructured":"Huang CY, Ju DT, Chang CF, Reddy PM, Velmurugan BK (2017) A review on the effects of current chemotherapy drugs and natural agents in treating non\u2013small cell lung cancer. Biomedicine 24(4):23. https:\/\/doi.org\/10.1051\/bmdcn\/2017070423","journal-title":"Biomedicine"},{"issue":"2","key":"4407_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ijc.32719","volume":"15","author":"S Jack","year":"2020","unstructured":"Jack S, Madhivanan K, Ramadesikan S, Subramanian S et al (2020) A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera. Int J Cancer 15(2):449\u2013460. https:\/\/doi.org\/10.1002\/ijc.32719","journal-title":"Int J Cancer"},{"key":"4407_CR22","doi-asserted-by":"publisher","first-page":"100564","DOI":"10.1016\/j.onehlt.2023.100564","volume":"1","author":"M Jayaprakasam","year":"2023","unstructured":"Jayaprakasam M, Chatterjee N, Chanda MM, Shahabuddin SM, Singhai M, Tiwari S, Panda S (2023) Human anthrax in India in recent times: a systematic review & risk mapping. One Health 1:16:100564. https:\/\/doi.org\/10.1016\/j.onehlt.2023.100564","journal-title":"One Health"},{"issue":"22","key":"4407_CR23","doi-asserted-by":"publisher","first-page":"35835","DOI":"10.18632\/oncotarget.16214","volume":"8","author":"R Khandia","year":"2017","unstructured":"Khandia R, Pattnaik B, Rajukumar K, Pateriya A, Bhatia S, Murugkar H et al (2017) Anti-proliferative role of Recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential. Oncotarget 8(22):35835. https:\/\/doi.org\/10.18632\/oncotarget.16214","journal-title":"Oncotarget"},{"key":"4407_CR24","doi-asserted-by":"publisher","unstructured":"Kreitman RJ (2000) Chimeric toxins in cancer treatment. Emerging Drugs 1; 5(1):61\u201371. https:\/\/doi.org\/10.1517\/14728214.5.1.61","DOI":"10.1517\/14728214.5.1.61"},{"issue":"12","key":"4407_CR25","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1128\/iai.01011-12","volume":"80","author":"M Langer","year":"2012","unstructured":"Langer M, Duggan ES, Booth JL, Patel VI, Zander RA et al (2012) Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun 80(12):4374\u20134387. https:\/\/doi.org\/10.1128\/iai.01011-12","journal-title":"Infect Immun"},{"key":"4407_CR26","doi-asserted-by":"publisher","unstructured":"Liu S, Aaronson H, Mitola DJ, Leppla SH, Bugge TH (2003) Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proceedings of the national academy of sciences 100(2):657\u2013\u200962. https:\/\/doi.org\/10.1073\/pnas.0236849100","DOI":"10.1073\/pnas.0236849100"},{"issue":"1","key":"4407_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1074\/jbc.M707419200","volume":"283","author":"S Liu","year":"2008","unstructured":"Liu S, Wang H, Currie BM, Molinolo A, Leung HJ, Moayeri M, Basile JR, Alfano RW, Gutkind JS, Frankel AE, Bugge TH (2008) Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 283(1):529\u2013540. https:\/\/doi.org\/10.1074\/jbc.M707419200","journal-title":"J Biol Chem"},{"issue":"39","key":"4407_CR28","doi-asserted-by":"publisher","first-page":"65123","DOI":"10.18632\/oncotarget.17729","volume":"8","author":"S Liu","year":"2017","unstructured":"Liu S, Ma Q, Fattah R, Bugge TH, Leppla SH (2017) Anti-tumor activity of anthrax toxin variants that form a functional translocation pore by intermolecular complementation. Oncotarget 8(39):65123. https:\/\/doi.org\/10.18632\/oncotarget.17729","journal-title":"Oncotarget"},{"issue":"19","key":"4407_CR29","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/cbic.202000201","volume":"1","author":"AR Loftis","year":"2020","unstructured":"Loftis AR, Santos MS, Truex NL, Biancucci M, Satchell KJF, Pentelute BL (2020) Anthrax protective antigen retargeted with single-chain variable fragments delivers enzymes to pancreatic cancer cells. ChemBioChem 1(19):2772\u20132776. https:\/\/doi.org\/10.1002\/cbic.202000201","journal-title":"ChemBioChem"},{"issue":"6","key":"4407_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1021\/acschembio.9b01027","volume":"15","author":"Z Lu","year":"2020","unstructured":"Lu Z, Paolella BR, Truex NL, Loftis AR, Liao X, Rabideau AE, Brown MS, Busanovich J, Beroukhim R, Pentelute BL (2020) Targeting cancer gene dependencies with anthrax-mediated delivery of peptide nucleic acids. ACS Chem Biol 15(6):1358\u20131369. https:\/\/doi.org\/10.1021\/acschembio.9b01027","journal-title":"ACS Chem Biol"},{"key":"4407_CR31","doi-asserted-by":"publisher","unstructured":"Mackowiak da Fonseca J, Mackowiak da Fonseca II, Nagamine MK, Massoco CO, Nishiya AT, Ward JM, Liu S, Leppla SH, Bugge TH, Dagli MLZ (2020) Inhibitory effects of a reengineered anthrax toxin on canine and human osteosarcoma cells. Toxins (Basel) 12(10):614. https:\/\/doi.org\/10.3390\/toxins12100614","DOI":"10.3390\/toxins12100614"},{"key":"4407_CR32","doi-asserted-by":"publisher","unstructured":"Mahmood A, Srivastava R (2022) Etiology of cancer. In: Understanding cancer, vol 1. Academic Press, p 37\u201362. https:\/\/doi.org\/10.1016\/B978-0-323-99883-3.00008-1","DOI":"10.1016\/B978-0-323-99883-3.00008-1"},{"key":"4407_CR33","doi-asserted-by":"publisher","unstructured":"Marquez-Lopez A, Fanarraga ML (2024) Engineering an anthrax toxin inspired protein-ligand for nanoparticle-mediated treatment of malignant melanoma. https:\/\/doi.org\/10.1101\/2024.12.05.626996. bioRxiv 2024-12","DOI":"10.1101\/2024.12.05.626996"},{"issue":"32","key":"4407_CR34","doi-asserted-by":"publisher","first-page":"33534","DOI":"10.18632\/oncotarget.5214","volume":"6","author":"EW Martin","year":"2015","unstructured":"Martin EW, Buzza MS, Driesbaugh KH, Liu S, Fortenberry YM, Leppla SH, Antalis TM (2015) Targeting the membrane-anchored Serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden. Oncotarget 6(32):33534. https:\/\/doi.org\/10.18632\/oncotarget.5214","journal-title":"Oncotarget"},{"issue":"3","key":"4407_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.molonc.2012.12.003","volume":"7","author":"AJ McCluskey","year":"2013","unstructured":"McCluskey AJ, Olive AJ, Starnbach MN, Collier RJ (2013) Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol Oncol 7(3):440\u2013451. https:\/\/doi.org\/10.1016\/j.molonc.2012.12.003","journal-title":"Mol Oncol"},{"key":"4407_CR36","doi-asserted-by":"publisher","first-page":"111373","DOI":"10.1016\/j.microc.2024.111373","volume":"5","author":"F Moradi","year":"2024","unstructured":"Moradi F, Nasoohian N, Ghorbanian N, Fooladfar Z (2024) Recent advances in laboratory detection of Chlamydia trachomatis using gold (Au) nanoparticle-based methods; another evolution of nanotechnology in diagnostic bacteriology. Microchem J 5:111373","journal-title":"Microchem J"},{"issue":"9","key":"4407_CR37","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/cncr.29140","volume":"1","author":"LG Morris","year":"2015","unstructured":"Morris LG, Chan TA (2015) Therapeutic targeting of tumor suppressor genes. Cancer 1(9):1357\u20131368. https:\/\/doi.org\/10.1002\/cncr.29140","journal-title":"Cancer"},{"key":"4407_CR38","doi-asserted-by":"publisher","first-page":"104075","DOI":"10.1016\/j.pdpdt.2024.104075","volume":"46","author":"S Nasrollahian","year":"2024","unstructured":"Nasrollahian S, Moradi F, Hadi N, Ranjbar S, Ranjbar R (2024) An update on alternative therapy for Escherichia coli causing urinary tract infections; a narrative review. Photodiagnosis Photodyn Ther 46:104075. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104075","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4407_CR39","doi-asserted-by":"publisher","unstructured":"Nestorovich EM, Bezrukov SM (2014) Designing inhibitors of anthrax toxin. Expert Opin Drug Discov 9(3):299\u2013318. https:\/\/doi.org\/10.1517\/17460441.2014.877884","DOI":"10.1517\/17460441.2014.877884"},{"issue":"2","key":"4407_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.18051\/JBiomedKes.2019.v2.130-131","volume":"26","author":"ML Parwanto","year":"2019","unstructured":"Parwanto ML (2019) Deteksi spora Bacillus anthracis. Jurnal Biomedika Dan Kesehatan 26(2):130\u2013131. https:\/\/doi.org\/10.18051\/JBiomedKes.2019.v2.130-131","journal-title":"Jurnal Biomedika Dan Kesehatan"},{"issue":"13","key":"4407_CR41","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.1074\/jbc.M113.452110","volume":"288","author":"DD Phillips","year":"2013","unstructured":"Phillips DD, Fattah RJ, Crown D, Zhang Y, Liu S, Moayeri M, Fischer ER, Hansen BT, Ghirlando R, Nestorovich EM, Wein AN (2013) Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors. J Biol Chem 288(13):9058\u20139065. https:\/\/doi.org\/10.1074\/jbc.M113.452110","journal-title":"J Biol Chem"},{"issue":"5","key":"4407_CR42","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1172\/JCI19581","volume":"1","author":"AS Prince","year":"2003","unstructured":"Prince AS (2003) The host response to anthrax lethal toxin: unexpected observations. J Clin Investig 1(5):656\u2013658. https:\/\/doi.org\/10.1172\/JCI19581","journal-title":"J Clin Investig"},{"issue":"S3","key":"4407_CR43","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1017\/S1431927615005280","volume":"21","author":"CM Rodenburg","year":"2015","unstructured":"Rodenburg CM, McPherson SA, Turnbough CL Jr, Dokland T (2015) Structure and assembly of the Bacillus anthracis exosporium. Microsc Microanal 21(S3):897\u2013898. https:\/\/doi.org\/10.1017\/S1431927615005280","journal-title":"Microsc Microanal"},{"issue":"4","key":"4407_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.32607\/actanaturae.11387","volume":"13","author":"YO Romanenko","year":"2021","unstructured":"Romanenko YO, Riabko AK, Marin MA, Kartseva AS, Silkina MV, Shemyakin IG, Firstova VV (2021) Mechanism of action of monoclonal antibodies that block the activity of the lethal toxin of Bacillus anthracis. Acta Nat 13(4):98. https:\/\/doi.org\/10.32607\/actanaturae.11387","journal-title":"Acta Naturae"},{"issue":"1","key":"4407_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1535-7163.MCT-05-0163","volume":"5","author":"B R\u00f8n\u00f8","year":"2006","unstructured":"R\u00f8n\u00f8 B, R\u00f8mer J, Liu S, Bugge TH, Leppla SH, Kristjansen PE (2006) Antitumor efficacy of a urokinase activation\u2013dependent anthrax toxin. Mol Cancer Ther 5(1):89\u201396. https:\/\/doi.org\/10.1158\/1535-7163.MCT-05-0163","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"4407_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/toxins17020056","volume":"24","author":"N Sangwan","year":"2025","unstructured":"Sangwan N, Gangwal A, Jain P, Langtso C, Srivastava S, Dhawan U et al (2025) Anthrax: transmission, pathogenesis, prevention and treatment. Toxins 24(2):56. https:\/\/doi.org\/10.3390\/toxins17020056","journal-title":"Toxins"},{"issue":"5","key":"4407_CR47","doi-asserted-by":"publisher","first-page":"e20532","DOI":"10.1371\/journal.pone.0020532","volume":"6","author":"JM Schafer","year":"2011","unstructured":"Schafer JM, Peters DE, Morley T, Liu S, Molinolo AA, Leppla SH, Bugge TH (2011) Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin. PLoS ONE 6(5):e20532. https:\/\/doi.org\/10.1371\/journal.pone.0020532","journal-title":"PLoS ONE"},{"issue":"10","key":"4407_CR48","doi-asserted-by":"publisher","first-page":"e1006690","DOI":"10.1371\/journal.ppat.1006690","volume":"23","author":"S Seshadri","year":"2017","unstructured":"Seshadri S, Allan DS, Carlyle JR, Zenewicz LA (2017) Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling. PLoS Pathog 23(10):e1006690. https:\/\/doi.org\/10.1371\/journal.ppat.1006690","journal-title":"PLoS Pathog"},{"issue":"4","key":"4407_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4251\/wjgo.v13.i4.216","volume":"13","author":"KR Sun","year":"2021","unstructured":"Sun KR, Lv HF, Chen BB, Nie CY, Zhao J, Chen XB (2021) Latest therapeutic target for gastric cancer: anthrax toxin receptor 1. World J Gastrointest Oncol 13(4):216. https:\/\/doi.org\/10.4251\/wjgo.v13.i4.216","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"4407_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/antib2010082","volume":"28","author":"NN Waldron","year":"2013","unstructured":"Waldron NN, Vallera DA (2013) An old Idea tackling a new problem: targeted toxins specific for cancer stem cells. Antibodies 28(1):82\u201392. https:\/\/doi.org\/10.3390\/antib2010082","journal-title":"Antibodies"},{"issue":"1","key":"4407_CR51","doi-asserted-by":"publisher","first-page":"16267","DOI":"10.1038\/srep16267","volume":"20","author":"AN Wein","year":"2015","unstructured":"Wein AN, Peters DE, Valivullah Z, Hoover BJ, Tatineni A, Ma Q et al (2015) An anthrax toxin variant with an improved activity in tumor targeting. Sci Rep 20(1):16267. https:\/\/doi.org\/10.1038\/srep16267","journal-title":"Sci Rep"},{"key":"4407_CR52","unstructured":"World Cancer Day (2024) Media centre https:\/\/www.emro.who.int\/media\/news\/world-cancer-day-2024.html"},{"key":"4407_CR53","doi-asserted-by":"publisher","first-page":"41252","DOI":"10.1038\/srep41252","volume":"7","author":"NI Zahaf","year":"2017","unstructured":"Zahaf NI, Lang A, Kaiser L et al (2017) Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells. Sci Rep 7:41252. https:\/\/doi.org\/10.1038\/srep41252","journal-title":"Sci Rep"},{"issue":"1","key":"4407_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/microorganisms8010125","volume":"8","author":"AA Zasada","year":"2020","unstructured":"Zasada AA (2020) Detection and identification of Bacillus anthracis: from conventional to molecular microbiology methods. Microorganisms 8(1):125. https:\/\/doi.org\/10.3390\/microorganisms8010125","journal-title":"Microorganisms"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04407-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:52:47Z","timestamp":1757321567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04407-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"type":"print","value":"0302-8933"},{"type":"electronic","value":"1432-072X"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"205"}}